Boehringer Ingelheim

Boehringer Ingelheim is a research-driven pharmaceutical company and a global group of companies that embraces diverse cultures and societies. The goal of Boehringer Ingelheim is to improve the health and quality of life of humans and animals.

Boehringer Ingelheim focuses on diseases that have no satisfactory treatment option up till date. The company therefore focuses on developing therapies that can extend patients’ lives. Boehringer Ingelheim stands for advanced prevention in animal health.

The company continues to develop therapies and healthcare solutions in areas of challenging and unmet medical need. The company aspires to make sustainable delivery of healthcare to humans, animals and communities around the world by creating initiatives, both commercial and philanthropic, based on local empowerment and partnerships.

As part of research and development activities for innovative drugs, the company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.